Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.
about
Angiotensin receptor blockers for heart failureAngiotensin receptor blockers in heart failure after the ELITE II trialThe Different Therapeutic Choices with ARBs. Which One to Give? When? Why?The autocrine/paracrine loop after myocardial stretch: mineralocorticoid receptor activationClinical trials update from the European Society of Cardiology: CHARM, BASEL, EUROPA and ESTEEMAngiotensin-converting enzyme 2 as a novel target for gene therapy for hypertensionAngiotensin AT(1) receptor signalling modulates reparative angiogenesis induced by limb ischaemiaEffects of ACE inhibition and angiotensin II type 1 receptor blockade on cardiac function and G proteins in rats with chronic heart failureAngiotensin receptor blockers for chronic heart failure and acute myocardial infarctionMeta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failureComparing angiotensin II receptor blockers on benefits beyond blood pressureRAAS inhibitors and cardiovascular protection in large scale trials.The renin-angiotensin system and its blockade in diabetic renal and cardiovascular disease.New competition in the realm of renin-angiotensin axis inhibition; the angiotensin II receptor antagonists in congestive heart failure.Combined therapy with an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor in heart failure.Changes in heart failure medications in patients hospitalised and discharged.Heart failure management: the present and the future.Differential efficacy profile of aldosterone receptor antagonists, depending on the type of chronic heart failure, whether with reduced or preserved left ventricular ejection fraction-results of a meta-analysis of randomized controlled trialsCirculating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI-atrial fibrillation trial.Hypertensive therapy: attacking the renin-angiotensin systemAliskiren, the first direct renin inhibitor: assessing a role in pediatric hypertension and kidney diseases.Pharmacologic, pharmacokinetic, and therapeutic differences among angiotensin II receptor antagonists.Accuracy of noninvasive ejection fraction measurement in a large community-based clinic.Cardiomyopathy. Diagnosis and management of dilated cardiomyopathyCheyne-stokes respiration and prognosis in modern-treated congestive heart failure'ACE inhibitors are better than AT(1) receptor blockers (ARBs)' - controversies in heart failure.Therapeutic implications of escape from angiotensin-converting enzyme inhibition in patients with chronic heart failure.Recent advances in the management of chronic heart failure.Optimal strategies for preventing progression of renal disease: should angiotensin converting enzyme inhibitors and angiotensin receptor blockers be used together?New and emerging pharmacologic strategies in the management of chronic heart failure.Angiotensin receptor blockers and risk of myocardial infarction: systematic review.Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current statusAldosterone antagonists in the treatment of hypertension and target organ damage.Ace revisited: a new target for structure-based drug design.Angiotensin II receptor (AT1) antagonists in heart failure after Val-HeFT--Quo Vadis?Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure.Candesartan.Clinical effectiveness of telmisartan alone or in combination therapy for controlling blood pressure and vascular risk in the elderlyDifferentiation in the angiotensin II receptor 1 blocker class on autonomic function.Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in combination: theory and practice.
P2860
Q24199125-84AB9F6E-7695-4953-BAA9-07FEF4EE9D0BQ24792591-0FDABB4E-BC14-470A-A155-D966A3306496Q26768696-B8F659C8-6EAA-4375-B2B2-8D46BEB97114Q26826836-91D8A809-A3BA-4647-812B-800E036C2A6CQ28166022-7ABD2093-4672-4E88-AF06-7DB272721A46Q28301752-D2C7C68D-9332-4BDE-935A-E37554642C94Q28344851-B0A4BF5A-33A6-41E4-8526-FFF64781DCA6Q28346745-338E20A1-5D96-4A58-88E1-A9A181601865Q28366894-D257B649-DFF7-4C16-82B0-B5E4DBB201AFQ28748219-E1387F4F-78DD-46D5-B67E-A0154559B8FDQ30360678-7C7C2846-6F8F-4C13-96DC-392CC7CC4943Q30424541-FA1779BB-A366-4B68-899C-8D8664DF1AC1Q30439734-E0A35E89-6358-42CE-A0B2-7CB92B67AA3CQ31989723-9CFF90BD-CE33-4DCD-8323-3F8B51EC8939Q32052998-084987F3-DB5A-42D4-A0F6-9B541B9C6D9EQ33264476-5522B118-54C0-41E6-A333-AC8A986D6065Q33605156-A8032878-6D58-435F-BF65-C8C9503A7535Q33714645-F1C81AA7-2836-4499-BB65-629E24BABB18Q33724642-2BE57F89-7D89-4334-A29B-40D036F46C28Q33729203-8BD8DC41-95AB-42B3-8E81-8A2140B800C2Q33756874-878BFD22-EF5F-4190-B7E1-A1D350EDC4E2Q33839744-3B3DEFBD-387A-4A06-A827-3BCEED93240CQ33913587-E0C11A98-48C5-4639-89D9-87C02C259EE9Q33947702-8973D7EF-C1F0-4512-AE79-5EF3B76FA1E9Q33970002-FEB035D4-10FA-49C6-9274-7FFB71481748Q33999933-97620B94-25A6-4D3B-AD14-CB1EB734E1AEQ34027512-B5C04E21-99F5-439E-B5E4-98EA58B16BB4Q34031741-A25F8EA3-E77B-448F-8B90-8DE2BC087B22Q34038063-F765DC86-7B03-4E80-AD03-8DA79BF7425FQ34075359-1227D04C-94A2-43F8-A5E8-243537746FA4Q34081519-CB397E59-DA78-4E75-BB76-DF2E471677F3Q34124779-5B1D2802-71BE-42EE-9410-45907097C3C5Q34251366-951D3354-909E-45B9-AE04-8B1CC177DFF7Q34282839-68592F98-2269-4944-9B5E-9A2E36254653Q34286755-4A8EF211-4BAF-4AB9-8FC7-F090B8C34CD5Q34324771-1D38F913-C3D1-4CBD-A00F-DCA20659E13DQ34375649-E7F96027-67FF-4AFC-AB56-09F02A6F3882Q34386587-4370D5A0-042A-4921-BAB0-E3056872D189Q34387690-53A305CB-2BD5-4E71-AE60-06153454B511Q34448803-D00C1184-CDAE-4F0A-B032-82E3AFEEE9DA
P2860
Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Comparison of candesartan, ena ...... LVD Pilot Study Investigators.
@en
Comparison of candesartan, ena ...... LVD Pilot Study Investigators.
@nl
type
label
Comparison of candesartan, ena ...... LVD Pilot Study Investigators.
@en
Comparison of candesartan, ena ...... LVD Pilot Study Investigators.
@nl
prefLabel
Comparison of candesartan, ena ...... LVD Pilot Study Investigators.
@en
Comparison of candesartan, ena ...... LVD Pilot Study Investigators.
@nl
P2093
P1433
P1476
Comparison of candesartan, ena ...... LVD Pilot Study Investigators.
@en
P2093
A Maggioni
J Probstfield
P304
P356
10.1161/01.CIR.100.10.1056
P407
P577
1999-09-01T00:00:00Z